InvestorsHub Logo
Followers 36
Posts 5775
Boards Moderated 0
Alias Born 02/20/2015

Re: SAMNOTSAMUEL post# 24772

Wednesday, 11/15/2017 8:39:26 PM

Wednesday, November 15, 2017 8:39:26 PM

Post# of 50157
Nonsense. This is all that you need to know until next quarter, IMO:

Increasing revenues and a liver cancer treatment in Phase III trials are two key factors in what continues to make us interested in the DCTH story.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News